The International Society on Thrombosis and Haemostasis (ISTH) has announced the election of Mary Cushman, M.D.’89, M.Sc., as the ISTH president for the 2028–2030 term.

Her tenure will begin with a term as ISTH president-elect from 2026 to 2028, working closely with incoming ISTH President Wolfram Ruf, M.D., to support the ISTH Council and provide strategic direction on the activities of the society. Per the ISTH leadership structure, Dr. Cushman will begin her role as ISTH president in 2028 at the conclusion of the ISTH 2028 Congress.

Cushman is a University Distinguished Professor of Medicine and Pathology & Laboratory Medicine at the Larner College of Medicine at the University of Vermont, where she also serves as vice chair for emerging researchers of the Department of Medicine, director of the Thrombosis and Hemostasis Program in the Hematology-Oncology Division, board director of the Cardiovascular Research Institute, and co-director of the Vermont Center for Cardiovascular and Brain Health, which is a National Institutes of Health (NIH)–funded Center of Biomedical Research Excellence.

“Dr. Cushman’s longstanding commitment to the mission of the ISTH, combined with her distinguished record of research, mentorship, and service within the society, position her exceptionally well to guide the ISTH in the future,” said ISTH President Pantep Angchaisuksiri, M.D. “We are confident that her expertise and collaborative leadership style will strengthen our global community and further elevate the impact of the ISTH worldwide.”

As a longstanding leader at the ISTH, Cushman has served on a variety of ISTH committees and currently sits on the ISTH Council. From 2016 to 2023, she was the inaugural editor-in-chief of Research and Practice in Thrombosis and Haemostasis (RPTH). She has published more than 800 peer-reviewed articles, 25 guidelines or society statements, and more than 70 reviews. A dedicated mentor, Cushman has trained more than 30 research students, most of whom remain in academia. 

“Dr. Cushman’s longstanding commitment to the mission of the ISTH, combined with her distinguished record of research, mentorship, and service within the society, position her exceptionally well to guide the ISTH in the future.” — ISTH President Pantep Angchaisuksiri, M.D.

“I’m thrilled to step into this role, which gives me the opportunity to give back to an organization that has meant so much to me for over 30 years,” said Cushman. “I look forward to collaboratively advancing the ISTH’s mission globally, including in low‑ and middle‑income countries, strengthening research opportunities, supporting our members, and ensuring that scientific advances reach patients everywhere.” 

The ISTH president is elected from among the previously elected ISTH Council members. After a nomination period, councilors with voting privileges review the nominations and cast a ballot. The individual receiving the most votes is appointed as president-elect. The term is two years as president-elect, followed by two-years as ISTH president, beginning and ending at the ISTH Congress.

About the ISTH

Founded in 1969, the ISTH is the leading international medical and scientific professional organization dedicated to advancing the understanding, prevention, diagnosis and treatment of conditions related to thrombosis and hemostasis. The ISTH professional membership community includes more than 7,000 clinicians, researchers and educators from more than 120 countries working together to advance science and improve clinical care around the world. Among its highly-regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, clinical and laboratory practice guidance and guidelines, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Learn more about the ISTH at www.isth.org.